Global ED Treatment Market Insights and Forecast to 2028

Q: Who are the key players in the ed treatment market?

Some of the key players are Eli Lilly, Pfizer Inc, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO, Company, Japan, Others.

Code: QYRE-Auto-25A462

Report

January 2022

114 Pages

QYResearch

Region: Global, North America, China, Europe, Japan, Germany, France, Australia, India, South Korea, Taiwan, Turkey, Italy, Philippines, Malaysia, Thailand, Indonesia, Saudi Arabia,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Eli Lilly

Pfizer Inc

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

CSBIO

Company

Japan

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

Market Analysis and Insights: Global ED Treatment Market

Due to the COVID-19 pandemic, the global ED Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Sildenafil accounting for % of the ED Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China ED Treatment market size is valued at US$ million in 2021, while the US and Europe ED Treatment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe ED Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of ED Treatment include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma and Seoul Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global ED Treatment Scope and Segment

ED Treatment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global ED Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Sildenafil

Tadalafil

Others

Segment by Application

Hospitals

Drugstores

Other

BY COMPANY

Eli Lilly

Pfizer

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

CSBIO.

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Eli Lilly

Pfizer Inc

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

CSBIO

Company

Japan

1 Study Coverage

1.1 ED Treatment Product Introduction

1.2 Market by Type

1.2.1 Global ED Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Sildenafil

1.2.3 Tadalafil

1.2.4 Others

1.3 Market by Application

1.3.1 Global ED Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global ED Treatment Sales Estimates and Forecasts 2017-2028

2.2 Global ED Treatment Revenue Estimates and Forecasts 2017-2028

2.3 Global ED Treatment Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global ED Treatment Sales by Region

2.4.1 Global ED Treatment Sales by Region (2017-2022)

2.4.2 Global Sales ED Treatment by Region (2023-2028)

2.5 Global ED Treatment Revenue by Region

2.5.1 Global ED Treatment Revenue by Region (2017-2022)

2.5.2 Global ED Treatment Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global ED Treatment Sales by Manufacturers

3.1.1 Global Top ED Treatment Manufacturers by Sales (2017-2022)

3.1.2 Global ED Treatment Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of ED Treatment in 2021

3.2 Global ED Treatment Revenue by Manufacturers

3.2.1 Global ED Treatment Revenue by Manufacturers (2017-2022)

3.2.2 Global ED Treatment Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by ED Treatment Revenue in 2021

3.3 Global ED Treatment Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global ED Treatment Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global ED Treatment Sales by Type

4.1.1 Global ED Treatment Historical Sales by Type (2017-2022)

4.1.2 Global ED Treatment Forecasted Sales by Type (2023-2028)

4.1.3 Global ED Treatment Sales Market Share by Type (2017-2028)

4.2 Global ED Treatment Revenue by Type

4.2.1 Global ED Treatment Historical Revenue by Type (2017-2022)

4.2.2 Global ED Treatment Forecasted Revenue by Type (2023-2028)

4.2.3 Global ED Treatment Revenue Market Share by Type (2017-2028)

4.3 Global ED Treatment Price by Type

4.3.1 Global ED Treatment Price by Type (2017-2022)

4.3.2 Global ED Treatment Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global ED Treatment Sales by Application

5.1.1 Global ED Treatment Historical Sales by Application (2017-2022)

5.1.2 Global ED Treatment Forecasted Sales by Application (2023-2028)

5.1.3 Global ED Treatment Sales Market Share by Application (2017-2028)

5.2 Global ED Treatment Revenue by Application

5.2.1 Global ED Treatment Historical Revenue by Application (2017-2022)

5.2.2 Global ED Treatment Forecasted Revenue by Application (2023-2028)

5.2.3 Global ED Treatment Revenue Market Share by Application (2017-2028)

5.3 Global ED Treatment Price by Application

5.3.1 Global ED Treatment Price by Application (2017-2022)

5.3.2 Global ED Treatment Price Forecast by Application (2023-2028)

6 North America

6.1 North America ED Treatment Market Size by Type

6.1.1 North America ED Treatment Sales by Type (2017-2028)

6.1.2 North America ED Treatment Revenue by Type (2017-2028)

6.2 North America ED Treatment Market Size by Application

6.2.1 North America ED Treatment Sales by Application (2017-2028)

6.2.2 North America ED Treatment Revenue by Application (2017-2028)

6.3 North America ED Treatment Market Size by Country

6.3.1 North America ED Treatment Sales by Country (2017-2028)

6.3.2 North America ED Treatment Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe ED Treatment Market Size by Type

7.1.1 Europe ED Treatment Sales by Type (2017-2028)

7.1.2 Europe ED Treatment Revenue by Type (2017-2028)

7.2 Europe ED Treatment Market Size by Application

7.2.1 Europe ED Treatment Sales by Application (2017-2028)

7.2.2 Europe ED Treatment Revenue by Application (2017-2028)

7.3 Europe ED Treatment Market Size by Country

7.3.1 Europe ED Treatment Sales by Country (2017-2028)

7.3.2 Europe ED Treatment Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific ED Treatment Market Size by Type

8.1.1 Asia Pacific ED Treatment Sales by Type (2017-2028)

8.1.2 Asia Pacific ED Treatment Revenue by Type (2017-2028)

8.2 Asia Pacific ED Treatment Market Size by Application

8.2.1 Asia Pacific ED Treatment Sales by Application (2017-2028)

8.2.2 Asia Pacific ED Treatment Revenue by Application (2017-2028)

8.3 Asia Pacific ED Treatment Market Size by Region

8.3.1 Asia Pacific ED Treatment Sales by Region (2017-2028)

8.3.2 Asia Pacific ED Treatment Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America ED Treatment Market Size by Type

9.1.1 Latin America ED Treatment Sales by Type (2017-2028)

9.1.2 Latin America ED Treatment Revenue by Type (2017-2028)

9.2 Latin America ED Treatment Market Size by Application

9.2.1 Latin America ED Treatment Sales by Application (2017-2028)

9.2.2 Latin America ED Treatment Revenue by Application (2017-2028)

9.3 Latin America ED Treatment Market Size by Country

9.3.1 Latin America ED Treatment Sales by Country (2017-2028)

9.3.2 Latin America ED Treatment Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa ED Treatment Market Size by Type

10.1.1 Middle East and Africa ED Treatment Sales by Type (2017-2028)

10.1.2 Middle East and Africa ED Treatment Revenue by Type (2017-2028)

10.2 Middle East and Africa ED Treatment Market Size by Application

10.2.1 Middle East and Africa ED Treatment Sales by Application (2017-2028)

10.2.2 Middle East and Africa ED Treatment Revenue by Application (2017-2028)

10.3 Middle East and Africa ED Treatment Market Size by Country

10.3.1 Middle East and Africa ED Treatment Sales by Country (2017-2028)

10.3.2 Middle East and Africa ED Treatment Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Corporation Information

11.1.2 Eli Lilly Overview

11.1.3 Eli Lilly ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Eli Lilly ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Eli Lilly Recent Developments

11.2 Pfizer

11.2.1 Pfizer Corporation Information

11.2.2 Pfizer Overview

11.2.3 Pfizer ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Pfizer ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Pfizer Recent Developments

11.3 Bayer

11.3.1 Bayer Corporation Information

11.3.2 Bayer Overview

11.3.3 Bayer ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Bayer ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bayer Recent Developments

11.4 BaiYunShan General Factory

11.4.1 BaiYunShan General Factory Corporation Information

11.4.2 BaiYunShan General Factory Overview

11.4.3 BaiYunShan General Factory ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 BaiYunShan General Factory ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 BaiYunShan General Factory Recent Developments

11.5 S.K. Chemicals

11.5.1 S.K. Chemicals Corporation Information

11.5.2 S.K. Chemicals Overview

11.5.3 S.K. Chemicals ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 S.K. Chemicals ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 S.K. Chemicals Recent Developments

11.6 Teva Pharma

11.6.1 Teva Pharma Corporation Information

11.6.2 Teva Pharma Overview

11.6.3 Teva Pharma ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Teva Pharma ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Teva Pharma Recent Developments

11.7 Dong-A ST

11.7.1 Dong-A ST Corporation Information

11.7.2 Dong-A ST Overview

11.7.3 Dong-A ST ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Dong-A ST ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Dong-A ST Recent Developments

11.8 Metuchen Pharma

11.8.1 Metuchen Pharma Corporation Information

11.8.2 Metuchen Pharma Overview

11.8.3 Metuchen Pharma ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Metuchen Pharma ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Metuchen Pharma Recent Developments

11.9 Seoul Pharma

11.9.1 Seoul Pharma Corporation Information

11.9.2 Seoul Pharma Overview

11.9.3 Seoul Pharma ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Seoul Pharma ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Seoul Pharma Recent Developments

11.10 CSBIO.

11.10.1 CSBIO. Corporation Information

11.10.2 CSBIO. Overview

11.10.3 CSBIO. ED Treatment Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 CSBIO. ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 CSBIO. Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 ED Treatment Industry Chain Analysis

12.2 ED Treatment Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 ED Treatment Production Mode & Process

12.4 ED Treatment Sales and Marketing

12.4.1 ED Treatment Sales Channels

12.4.2 ED Treatment Distributors

12.5 ED Treatment Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 ED Treatment Industry Trends

13.2 ED Treatment Market Drivers

13.3 ED Treatment Market Challenges

13.4 ED Treatment Market Restraints

14 Key Findings in The Global ED Treatment Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Eli Lilly

Pfizer Inc

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

CSBIO

Company

Japan

List of Tables

Table 1. Global ED Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Sildenafil

Table 3. Major Manufacturers of Tadalafil

Table 4. Major Manufacturers of Others

Table 5. Global ED Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global ED Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global ED Treatment Sales by Region (2017-2022) & (K Units)

Table 8. Global ED Treatment Sales Market Share by Region (2017-2022)

Table 9. Global ED Treatment Sales by Region (2023-2028) & (K Units)

Table 10. Global ED Treatment Sales Market Share by Region (2023-2028)

Table 11. Global ED Treatment Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global ED Treatment Revenue Market Share by Region (2017-2022)

Table 13. Global ED Treatment Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global ED Treatment Revenue Market Share by Region (2023-2028)

Table 15. Global ED Treatment Sales by Manufacturers (2017-2022) & (K Units)

Table 16. Global ED Treatment Sales Share by Manufacturers (2017-2022)

Table 17. Global ED Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global ED Treatment Revenue Share by Manufacturers (2017-2022)

Table 19. ED Treatment Price by Manufacturers (2017-2022) &(USD/Unit)

Table 20. Global ED Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global ED Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ED Treatment as of 2021)

Table 22. ED Treatment Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers ED Treatment Product Offered

Table 24. Date of Manufacturers Enter into ED Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global ED Treatment Sales by Type (2017-2022) & (K Units)

Table 27. Global ED Treatment Sales by Type (2023-2028) & (K Units)

Table 28. Global ED Treatment Sales Share by Type (2017-2022)

Table 29. Global ED Treatment Sales Share by Type (2023-2028)

Table 30. Global ED Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global ED Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global ED Treatment Revenue Share by Type (2017-2022)

Table 33. Global ED Treatment Revenue Share by Type (2023-2028)

Table 34. ED Treatment Price by Type (2017-2022) & (USD/Unit)

Table 35. Global ED Treatment Price Forecast by Type (2023-2028) & (USD/Unit)

Table 36. Global ED Treatment Sales by Application (2017-2022) & (K Units)

Table 37. Global ED Treatment Sales by Application (2023-2028) & (K Units)

Table 38. Global ED Treatment Sales Share by Application (2017-2022)

Table 39. Global ED Treatment Sales Share by Application (2023-2028)

Table 40. Global ED Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global ED Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global ED Treatment Revenue Share by Application (2017-2022)

Table 43. Global ED Treatment Revenue Share by Application (2023-2028)

Table 44. ED Treatment Price by Application (2017-2022) & (USD/Unit)

Table 45. Global ED Treatment Price Forecast by Application (2023-2028) & (USD/Unit)

Table 46. North America ED Treatment Sales by Type (2017-2022) & (K Units)

Table 47. North America ED Treatment Sales by Type (2023-2028) & (K Units)

Table 48. North America ED Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America ED Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America ED Treatment Sales by Application (2017-2022) & (K Units)

Table 51. North America ED Treatment Sales by Application (2023-2028) & (K Units)

Table 52. North America ED Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America ED Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America ED Treatment Sales by Country (2017-2022) & (K Units)

Table 55. North America ED Treatment Sales by Country (2023-2028) & (K Units)

Table 56. North America ED Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America ED Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe ED Treatment Sales by Type (2017-2022) & (K Units)

Table 59. Europe ED Treatment Sales by Type (2023-2028) & (K Units)

Table 60. Europe ED Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe ED Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe ED Treatment Sales by Application (2017-2022) & (K Units)

Table 63. Europe ED Treatment Sales by Application (2023-2028) & (K Units)

Table 64. Europe ED Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe ED Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe ED Treatment Sales by Country (2017-2022) & (K Units)

Table 67. Europe ED Treatment Sales by Country (2023-2028) & (K Units)

Table 68. Europe ED Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe ED Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific ED Treatment Sales by Type (2017-2022) & (K Units)

Table 71. Asia Pacific ED Treatment Sales by Type (2023-2028) & (K Units)

Table 72. Asia Pacific ED Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific ED Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific ED Treatment Sales by Application (2017-2022) & (K Units)

Table 75. Asia Pacific ED Treatment Sales by Application (2023-2028) & (K Units)

Table 76. Asia Pacific ED Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific ED Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific ED Treatment Sales by Region (2017-2022) & (K Units)

Table 79. Asia Pacific ED Treatment Sales by Region (2023-2028) & (K Units)

Table 80. Asia Pacific ED Treatment Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific ED Treatment Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America ED Treatment Sales by Type (2017-2022) & (K Units)

Table 83. Latin America ED Treatment Sales by Type (2023-2028) & (K Units)

Table 84. Latin America ED Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America ED Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America ED Treatment Sales by Application (2017-2022) & (K Units)

Table 87. Latin America ED Treatment Sales by Application (2023-2028) & (K Units)

Table 88. Latin America ED Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America ED Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America ED Treatment Sales by Country (2017-2022) & (K Units)

Table 91. Latin America ED Treatment Sales by Country (2023-2028) & (K Units)

Table 92. Latin America ED Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America ED Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa ED Treatment Sales by Type (2017-2022) & (K Units)

Table 95. Middle East and Africa ED Treatment Sales by Type (2023-2028) & (K Units)

Table 96. Middle East and Africa ED Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa ED Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa ED Treatment Sales by Application (2017-2022) & (K Units)

Table 99. Middle East and Africa ED Treatment Sales by Application (2023-2028) & (K Units)

Table 100. Middle East and Africa ED Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa ED Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa ED Treatment Sales by Country (2017-2022) & (K Units)

Table 103. Middle East and Africa ED Treatment Sales by Country (2023-2028) & (K Units)

Table 104. Middle East and Africa ED Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa ED Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 106. Eli Lilly Corporation Information

Table 107. Eli Lilly Description and Major Businesses

Table 108. Eli Lilly ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 109. Eli Lilly ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. Eli Lilly Recent Developments

Table 111. Pfizer Corporation Information

Table 112. Pfizer Description and Major Businesses

Table 113. Pfizer ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 114. Pfizer ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Pfizer Recent Developments

Table 116. Bayer Corporation Information

Table 117. Bayer Description and Major Businesses

Table 118. Bayer ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 119. Bayer ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Bayer Recent Developments

Table 121. BaiYunShan General Factory Corporation Information

Table 122. BaiYunShan General Factory Description and Major Businesses

Table 123. BaiYunShan General Factory ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 124. BaiYunShan General Factory ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. BaiYunShan General Factory Recent Developments

Table 126. S.K. Chemicals Corporation Information

Table 127. S.K. Chemicals Description and Major Businesses

Table 128. S.K. Chemicals ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 129. S.K. Chemicals ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. S.K. Chemicals Recent Developments

Table 131. Teva Pharma Corporation Information

Table 132. Teva Pharma Description and Major Businesses

Table 133. Teva Pharma ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 134. Teva Pharma ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Teva Pharma Recent Developments

Table 136. Dong-A ST Corporation Information

Table 137. Dong-A ST Description and Major Businesses

Table 138. Dong-A ST ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 139. Dong-A ST ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Dong-A ST Recent Developments

Table 141. Metuchen Pharma Corporation Information

Table 142. Metuchen Pharma Description and Major Businesses

Table 143. Metuchen Pharma ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 144. Metuchen Pharma ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. Metuchen Pharma Recent Developments

Table 146. Seoul Pharma Corporation Information

Table 147. Seoul Pharma Description and Major Businesses

Table 148. Seoul Pharma ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 149. Seoul Pharma ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. Seoul Pharma Recent Developments

Table 151. CSBIO. Corporation Information

Table 152. CSBIO. Description and Major Businesses

Table 153. CSBIO. ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 154. CSBIO. ED Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. CSBIO. Recent Developments

Table 156. Key Raw Materials Lists

Table 157. Raw Materials Key Suppliers Lists

Table 158. ED Treatment Distributors List

Table 159. ED Treatment Customers List

Table 160. ED Treatment Market Trends

Table 161. ED Treatment Market Drivers

Table 162. ED Treatment Market Challenges

Table 163. ED Treatment Market Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. ED Treatment Product Picture

Figure 3. Global ED Treatment Market Share by Type in 2021 & 2028

Figure 3. Sildenafil Product Picture

Figure 4. Tadalafil Product Picture

Figure 5. Others Product Picture

Figure 6. Global ED Treatment Market Share by Application in 2021 & 2028

Figure 7. Hospitals

Figure 8. Drugstores

Figure 9. Other

Figure 10. ED Treatment Report Years Considered

Figure 11. Global ED Treatment Sales 2017-2028 (K Units)

Figure 12. Global ED Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global ED Treatment Revenue 2017-2028 (US$ Million)

Figure 14. Global ED Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global ED Treatment Sales Market Share by Region (2017-2022)

Figure 16. Global ED Treatment Sales Market Share by Region (2023-2028)

Figure 17. North America ED Treatment Sales YoY (2017-2028) & (K Units)

Figure 18. North America ED Treatment Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe ED Treatment Sales YoY (2017-2028) & (K Units)

Figure 20. Europe ED Treatment Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific ED Treatment Sales YoY (2017-2028) & (K Units)

Figure 22. Asia-Pacific ED Treatment Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America ED Treatment Sales YoY (2017-2028) & (K Units)

Figure 24. Latin America ED Treatment Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa ED Treatment Sales YoY (2017-2028) & (K Units)

Figure 26. Middle East & Africa ED Treatment Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The ED Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of ED Treatment in the World: Market Share by ED Treatment Revenue in 2021

Figure 29. Global ED Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global ED Treatment Sales Market Share by Type (2017-2028)

Figure 31. Global ED Treatment Revenue Market Share by Type (2017-2028)

Figure 32. Global ED Treatment Sales Market Share by Application (2017-2028)

Figure 33. Global ED Treatment Revenue Market Share by Application (2017-2028)

Figure 34. North America ED Treatment Sales Market Share by Type (2017-2028)

Figure 35. North America ED Treatment Revenue Market Share by Type (2017-2028)

Figure 36. North America ED Treatment Sales Market Share by Application (2017-2028)

Figure 37. North America ED Treatment Revenue Market Share by Application (2017-2028)

Figure 38. North America ED Treatment Sales Share by Country (2017-2028)

Figure 39. North America ED Treatment Revenue Share by Country (2017-2028)

Figure 40. U.S. ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 41. Canada ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 42. Europe ED Treatment Sales Market Share by Type (2017-2028)

Figure 43. Europe ED Treatment Revenue Market Share by Type (2017-2028)

Figure 44. Europe ED Treatment Sales Market Share by Application (2017-2028)

Figure 45. Europe ED Treatment Revenue Market Share by Application (2017-2028)

Figure 46. Europe ED Treatment Sales Share by Country (2017-2028)

Figure 47. Europe ED Treatment Revenue Share by Country (2017-2028)

Figure 48. Germany ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 49. France ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 51. Italy ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 52. Russia ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific ED Treatment Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific ED Treatment Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific ED Treatment Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific ED Treatment Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific ED Treatment Sales Share by Region (2017-2028)

Figure 58. Asia Pacific ED Treatment Revenue Share by Region (2017-2028)

Figure 59. China ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 60. Japan ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 62. India ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 63. Australia ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 64. Taiwan ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 68. Philippines ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 69. Latin America ED Treatment Sales Market Share by Type (2017-2028)

Figure 70. Latin America ED Treatment Revenue Market Share by Type (2017-2028)

Figure 71. Latin America ED Treatment Sales Market Share by Application (2017-2028)

Figure 72. Latin America ED Treatment Revenue Market Share by Application (2017-2028)

Figure 73. Latin America ED Treatment Sales Share by Country (2017-2028)

Figure 74. Latin America ED Treatment Revenue Share by Country (2017-2028)

Figure 75. Mexico ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 76. Brazil ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 77. Argentina ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 78. Middle East and Africa ED Treatment Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa ED Treatment Revenue Market Share by Type (2017-2028)

Figure 80. Middle East and Africa ED Treatment Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa ED Treatment Revenue Market Share by Application (2017-2028)

Figure 82. Middle East and Africa ED Treatment Sales Share by Country (2017-2028)

Figure 83. Middle East and Africa ED Treatment Revenue Share by Country (2017-2028)

Figure 84. Turkey ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 85. Saudi Arabia ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 86. U.A.E ED Treatment Revenue (2017-2028) & (US$ Million)

Figure 87. ED Treatment Value Chain

Figure 88. ED Treatment Production Process

Figure 89. Channels of Distribution

Figure 90. Distributors Profiles

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global ED Treatment Market Insights and Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global ED Treatment Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-25A462

Global ED Treatment Market Insights and Forecast to 2028

Code: QYRE-Auto-25A462

Report

January 2022

114 Pages

QYResearch

Region: Global, North America, China, Europe, Japan, Germany, France, Australia, India, South Korea, Taiwan, Turkey, Italy, Philippines, Malaysia, Thailand, Indonesia, Saudi Arabia,

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-12T7632

Fri May 13 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-0T7466

Fri May 13 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-36U7490

Fri May 13 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-14C7602

Fri May 13 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions